Buy & Sell Hormel Foods Corp (HRL) – Hormel Foods Corp Price Today
Aura AI Summary
Key Stats
- $11.25BMarket Cap
- Consumer StaplesSector
- -20.81%3M Drawdown
- $13.20BEnterprise Value
- 5.72%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 105 daysTypical Hold Time
Hormel Foods Corp (HRL) is currently valued at a market capitalization of $11.25B, with an enterprise value of $13.20B. Over the past 52 weeks, Hormel Foods Corp has traded between a low of $20.43 and a high of $31.54, highlighting its annual price range. Over the past three months, Hormel Foods Corp has recorded a drawdown of -20.81%, reflecting recent price volatility. Hormel Foods Corp offers a dividend yield of 5.72%, with the most recent dividend of $0.29 paid on 13 Apr 26. On average, investors hold Hormel Foods Corp for approximately 105 days, indicating typical investor behavior on the platform.
About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Most Recent News
Credo Technology's rising market value sparks buy rating amid AI infrastructure growth and fiber optics competition.
Credo Technology's market value has surged aggressively, prompting analysis of its future prospects amid competition between copper and fiber optics technologies. The company is undergoing a transformation highlighted by its recent DustPhotonics deal...
BioVie nears data readout for potential first treatment targeting long COVID symptoms.
BioVie Inc is advancing its clinical trial for a novel treatment aimed at long COVID, a condition affecting around 17 million Americans with symptoms like brain fog and fatigue. The company has secured a $13 million grant, making it unique in receivi...
Law firm investigates Meridian for possible securities violations after stock drops 8.86% on weak earnings.
Bragar Eagel & Squire, P.C. is investigating Meridian Corporation for potential violations of federal securities laws following a significant stock price drop. Meridian reported weak first-quarter 2026 results, citing decreased SBA loan sale income a...
